Vitreoretinal SpecialistWestchester Medical CenterAssistant Professor, New York Medical CollegeValhalla, New York
OSN New York Retina 2024: Understanding how next-generation anti-VEGFs perform in real-world settings compared to trials
Ferhina S. Ali, MD, discussed the real-world efficacy and durability of next-generation anti-VEGF agents like faricimab and aflibercept 8 mg, emphasizing how large-scale data offers insights into their performance and safety beyond clinical trials.
Read More